SMi Group

Company white papers

CARB-X Chief Strategy Officer John Rex to Open Superbugs USA Summit

SMi Group

Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level.

Superbugs and Superdrugs USA, will discuss key principles in funding incentives and global strategy, while honing in on clinical developments.

Download this free white paper to find out more.

Available Downloads